Early treatment with disease modifying therapies (DMTs) is most effective in preventing progression of multiple sclerosis, according to a large-scale Danish study. The study “Early versus Later Treatment Start in Multiple Sclerosis – A Register Based Cohort Study” is to be presented at the 2018 Annual Meeting of the American Academy of Neurology (AAN). This … Continue reading Early treatment does delay MS disease progression, new study confirms
Why are DMTs – Drugs to treat MS – Resisted by so Many?
Many people with multiple sclerosis await the launch of each new disease modifying therapy (DMT), hoping it will bring some improvement. Meanwhile, a significant number of those in the same situation seem to ignore a new drug and carry on regardless. But why? Well, there are a number of reasons; let’s take a look at a … Continue reading Why are DMTs – Drugs to treat MS – Resisted by so Many?